{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:59Z","timestamp":1790727959786,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.intimp.2021.108452","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T13:51:27Z","timestamp":1641304287000},"page":"108452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Role of myeloid derived suppressor cells in sepsis"],"prefix":"10.1016","volume":"104","author":[{"given":"M.","family":"Malavika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sanju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Poorna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeraraghavan","family":"Vishnu Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Sidharthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3978-2874","authenticated-orcid":false,"given":"Praveen","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-1004","authenticated-orcid":false,"given":"Ullas","family":"Mony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108452_b0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/epi-2019-0329","article-title":"Epigenetic biomarkers for human sepsis and septic shock: Insights from immunosuppression","volume":"12","author":"Beltr\u00e1n-Garc\u00eda","year":"2020","journal-title":"Epigenomics"},{"key":"10.1016\/j.intimp.2021.108452_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of sepsis and potential therapeutic targets","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2021.108452_b0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","article-title":"Sepsis and Septic Shock \u2013 Basics of diagnosis, pathophysiology and clinical decision making","volume":"104","author":"Font","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.intimp.2021.108452_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00063-020-00683-2","article-title":"Goodbye SIRS? Innate, trained and adaptive immunity and pathogenesis of organ dysfunction","volume":"115","author":"Ghnewa","year":"2020","journal-title":"Medizinische Klinik - Intensivmedizin und Notfallmedizin"},{"key":"10.1016\/j.intimp.2021.108452_b0025","article-title":"Myeloid cells in sepsis-acquired immunodeficiency","volume":"1\u201315","author":"Venet","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2021.108452_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: The evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.intimp.2021.108452_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbrc.2019.12.041","article-title":"B lymphocytopenia and Bregs in a not-to-die murine sepsis model","volume":"523","author":"Umakoshi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2021.108452_b0040","article-title":"Alterations of B cells in immunosuppressive phase of septic shock patients\u2217","volume":"815\u2013821","author":"Dong","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.108452_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2628-x","article-title":"Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis","volume":"23","author":"Hollen","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.108452_b0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2021.108452_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01099","article-title":"Myeloid-derived suppressor cells: not only in tumor immunity","volume":"10","author":"Pawelec","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg heterogeneity, function, and homeostasis","volume":"10","author":"Shevyrev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109864","article-title":"Increased levels of myeloid-derived suppressor cells in esophageal cancer patients is associated with the complication of sepsis","volume":"125","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.108452_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age review-article","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/jof5020037","article-title":"Candida\/staphylococcal polymicrobial intra-abdominal infection: pathogenesis and perspectives for a novel form of trained innate immunity","volume":"5","author":"Esher","year":"2019","journal-title":"J. Fungi"},{"key":"10.1016\/j.intimp.2021.108452_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00327","article-title":"Myeloid derived suppressor cells sepsis","volume":"10","author":"Schrijver","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01401","article-title":"Circulating myeloid derived suppressor cells (MDSC) that accumulate in premalignancy share phenotypic and functional characteristics with MDSC in cancer","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0090","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/CM9.0000000000000349","article-title":"Prospect of using deep learning for predicting differentiation of myeloid progenitor cells after sepsis","volume":"132","author":"Ruan","year":"2019","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.intimp.2021.108452_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-02857-y","article-title":"Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study","volume":"24","author":"Waeckel","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.108452_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00109","article-title":"The generation and identity of human myeloid-derived suppressor cells","volume":"10","author":"Bergenfelz","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2021.108452_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12092571","article-title":"Granulocytic myeloid-derived suppressor cells in breast milk (BM-MDSC) correlate with gestational age and postnatal age and are influenced by infant\u2019s sex","volume":"12","author":"K\u00f6stlin-Gille","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2021.108452_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01299","article-title":"Early activation of myeloid-derived suppressor cells participate in sepsis-induced immune suppression via PD-L1\/PD-1 axis","volume":"11","author":"Ruan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0115","article-title":"Recent advances in myeloid-derived suppressor cell biology","author":"Yaseen","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2021.108452_b0120","doi-asserted-by":"crossref","unstructured":"C.R. Millrud, C. Bergenfelz, K. Leandersson, On the origin of myeloid-derived suppressor cells. vol. 8 www.impactjournals.com\/oncotarget (2017).","DOI":"10.18632\/oncotarget.12278"},{"key":"10.1016\/j.intimp.2021.108452_b0125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001223","article-title":"Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation","volume":"8","author":"Cassetta","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2021.108452_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041011","article-title":"Metabolic regulation of myeloid-derived suppressor cell function in cancer","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2021.108452_b0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00262-019-02476-9","article-title":"High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma","volume":"69","author":"Melief","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2021.108452_b0140","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biology"},{"key":"10.1016\/j.intimp.2021.108452_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00675","article-title":"Sepsis triggers a late expansion of functionally impaired tissue-vascular inflammatory monocytes during clinical recovery","volume":"11","author":"Baudesson de Chanville","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00949","article-title":"Myeloid-derived suppressor cells: Ductile targets in disease","volume":"10","author":"Consonni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0160","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","article-title":"Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates","volume":"68","author":"Cassetta","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2021.108452_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01369","article-title":"SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities","volume":"10","author":"Sangaletti","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1753425919842320","article-title":"Epigenetic and metabolic programming of innate immunity in sepsis","volume":"25","author":"Vachharajani","year":"2019","journal-title":"Innate Immun."},{"key":"10.1016\/j.intimp.2021.108452_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cei.13059","article-title":"Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period","volume":"191","author":"Schwarz","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.584712","article-title":"Myeloid-derived suppressor cells in pregnancy and the neonatal period","volume":"11","author":"K\u00f6stlin-Gille","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00899","article-title":"Dysregulated mucosal immunity and associated pathogeneses in preterm neonates","volume":"11","author":"Sampah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fimmu.2020.00688","article-title":"S100-alarmins are essential pilots of postnatal innate immune adaptation","volume":"11","author":"Viemann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2019.00108","article-title":"Sepsis: inflammation is a necessary evil","volume":"7","author":"Nedeva","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2021.108452_b0200","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/febs.15222","article-title":"Hypoxia-inducible factors in metabolic reprogramming during sepsis","volume":"J.287","author":"Vanderhaeghen","year":"2020","journal-title":"FEBS"},{"key":"10.1016\/j.intimp.2021.108452_b0205","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5935\/0103-507X.20190010","article-title":"Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study","volume":"31","author":"Martins","year":"2019","journal-title":"Rev. Bras. Ter. Intensiva"},{"key":"10.1016\/j.intimp.2021.108452_b0215","unstructured":"MDSC-Mediated Mechanisms of Immunosuppression. https:\/\/www.rndsystems.com\/pathways\/mdsc-mediated-mechanisms-of-immunosuppression."},{"issue":"4","key":"10.1016\/j.intimp.2021.108452_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00262-018-2277-y","article-title":"MDSCs in infectious diseases: regulation, roles, and readjustment","volume":"68","author":"Dorhoi","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.intimp.2021.108452_b0225","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10753-018-0939-8","article-title":"Immunometabolism: another road to sepsis and its therapeutic targeting","volume":"42","author":"Kumar","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2021.108452_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01043","article-title":"The metabolic basis of immune dysfunction following sepsis and trauma","volume":"11","author":"McBride","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.108452_b0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmolb.2019.00085","article-title":"Immunometabolism and sepsis: a role for HIF?","volume":"6","author":"Fitzpatrick","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.intimp.2021.108452_b0240","first-page":"11","article-title":"Sepsis immunometabolism: from defining sepsis to understanding how energy production affects immune response","volume":"1","author":"Koutroulis","year":"2019","journal-title":"Crit. Care Explor."},{"issue":"10","key":"10.1016\/j.intimp.2021.108452_b0245","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1172\/JCI128164","article-title":"Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice","volume":"129","author":"Liu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2021.108452_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.intimp.2021.108452_b0255","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/mi11030286","article-title":"Biomarkers for point-of-care diagnosis of sepsis","volume":"11","author":"Teggert","year":"2020","journal-title":"Micromachines"},{"issue":"12","key":"10.1016\/j.intimp.2021.108452_b0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/children7120309","article-title":"Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis","volume":"7","author":"Hincu","year":"2020","journal-title":"Children"},{"key":"10.1016\/j.intimp.2021.108452_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108037","article-title":"Non-classical monocytes and its potential in diagnosing sepsis post cardiac surgery","volume":"99","author":"Sebastian","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.108452_b0270","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc10031","article-title":"Granulocyte-colony stimulating factor (G-CSF) and granulo-cyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis","volume":"15","author":"Bo","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.108452_b0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/SHK.0b013e3181e14f78","article-title":"Ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects","volume":"34","author":"Noel","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2021.108452_b0280","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by pro-moting myeloid-derived suppressor cell function","volume":"207","author":"Sander","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.108452_b0285","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s11671-019-3209-2","article-title":"Ferumoxytol attenuates the function of MDSCs to ameliorate LPS-induced immunosuppression in sepsis","volume":"14","author":"Xu","year":"2019","journal-title":"Nanoscale Res. Lett."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921010882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921010882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:32:09Z","timestamp":1761586329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921010882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"alternative-id":["S1567576921010882"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108452","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of myeloid derived suppressor cells in sepsis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108452"}}